Sunali Y Mehta

14PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiological adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 05, 2026
TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.

|May 27, 2026
YBX1 Expression Marks Proliferative Tumour States with Context-Dependent Genomic Instability: A Pan-Cancer Analysis.

|Dec 30, 2025
<i>TP53</i> Splice Mutations Have Tumour-Independent Effects on Genomic Stability and Prognosis: An In Silico Study.

Apeksha Arun Bhandarkar, Noah Ethan Kelly-Foleni, Debina Sarkar

|Aug 29, 2025
Δ133p53 isoform enhances TLR4 function to promote tumor growth.

Sasini Polwatta Lekamlage, Alexandra N Boix De Jesus, Adriana Machado Saraiva

|Jan 21, 2023
Increased Expression of the Δ133p53β Isoform Enhances Brain Metastasis.

Alexandra N Boix De Jesus, Ahmad Taha, David Wang

|Oct 18, 2022
Impact of Clinical Data Veracity on Cancer Genomic Research.

Sunali Mehta, Deborah Wright, Michael A Black

Pageof 3

Frequent Collaborators

4 joint publications

Tania Slatter

3 joint publications

Cushla McKinney

3 joint publications

Debina Sarkar

3 joint publications

Antony W Braithwaite